Sleep and non-motor symptoms in Parkinson’s disease
Authors:
Open Access
- 22 January 2013
- journal article
- review article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 120 (4) , 565-569
Abstract
Beyond the cardinal motor symptoms, bradykinesia, rigidity, tremor and postural instability, defining the diagnosis of Parkinson’s disease, there is a big spectrum of non-motor features that patients may suffer from and that may reduce their quality of life. Non-motor symptoms are not only frequent but also often under-reported by patients and caregivers. As they are frequently under-recognized by clinicians, they remain consequently under-treated. This review wants to give a short overview of the importance of non-motor symptoms on patients’ quality of life and helpful assessment tools that might facilitate recognition of non-motor features during clinical setting. Given the wide range of non-motor symptoms in Parkinson’s disease, we concentrate on common issues such as depression and sleep disorders like sleep-onset insomnia or sleep maintenance insomnia and restless legs syndrome. Thereby, we present some recent studies that have investigated the efficacy of dopaminergic drugs, especially dopamine agonists, revealing possible treatment strategies and thus improving disease management.Keywords
This publication has 43 references indexed in Scilit:
- Measurement of patient-centered outcomes in Parkinson’s disease: What do patients really want from their treatment?Parkinsonism & Related Disorders, 2011
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)Movement Disorders, 2010
- Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson’s diseaseJournal of Neural Transmission, 2010
- A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorderJournal of Sleep Research, 2010
- Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of lifeMovement Disorders, 2009
- Olfactory loss may be a first sign of idiopathic Parkinson's diseaseMovement Disorders, 2007
- Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic studyJournal of Neural Transmission, 2006
- Sleep-related problems of Parkinson’s diseaseAge and Ageing, 2006
- Factors impacting on quality of life in Parkinson's disease: Results from an international surveyMovement Disorders, 2002
- The Nighttime Problems of Parkinsonʼs DiseaseClinical Neuropharmacology, 1988